BCG at Home: A First-in-kind Trial of Home-based Intravesical Bacillus Calmette-Guérin Delivery for High-risk Non–muscle-invasive Bladder Cancer

European Urology Focus · Published 2026-07-01 · DOI 10.1016/j.euf.2026.06.020

Authors (14)

Daniel J. Lee, Cheyenne Williams, Scott Soefje, Danielle Flynn, Stephanie Kessler, Lindsay Northern, Jinah Yoo, Alexander Radovanovich, David Kim, Donna Cappozzi, Aquilla Obare, Hanna Stambakio, Thomas Guzzo, Trinity J. Bivalacqua

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Lee, D., Williams, C., Soefje, S., et al. (2026). BCG at Home: A First-in-kind Trial of Home-based Intravesical Bacillus Calmette-Guérin Delivery for High-risk Non–muscle-invasive Bladder Cancer. European Urology Focus. https://doi.org/10.1016/j.euf.2026.06.020

Related articles

• Radioligand Therapy (RLT) in France · European Urology Focus · 2026 · Same journal
• Seeking a Credible Basis for Prostatic Obstruction as the Reversible Cause of Other Lower Urinary Tract Dysfunctions · European Urology Focus · 2026 · Same journal
• Discordant Response in Pelvic Lymph Nodes and Cystectomy Specimens After Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer · European Urology Focus · 2026 · Same journal
• Early-access Use of Radioligand Therapy in Prostate Cancer · European Urology Focus · 2026 · Same journal
• Genitourinary Injury After Radiation Therapy: Understanding Burden of Disease and Evolving Therapeutic Advancements · European Urology Focus · 2026 · Same journal
• Conceptualizing the “High” Bladder Neck – Anatomic Rabbit Hole or Functional Gold Mine? · European Urology Focus · 2026 · Same journal
• Postvoided Residual/Bladder Emptying: A Mini Review · European Urology Focus · 2026 · Same journal
• Dose-intensified PSMA Radioligand Therapy: The Rationale Behind the OPTIMAL-PSMA Trial · European Urology Focus · 2026 · Same journal
• Contemporary Prostate Cancer Intraprostatic Imaging Scores: A Practical and Hands-on Guide for Urologists · European Urology Focus · 2026 · Same journal
• Lutetium-177-PSMA-617 in Oligo-metastatic Hormone-sensitive Prostate Cancer (BULLSEYE): A Trial Update · European Urology Focus · 2026 · Same journal